Fox Run Management, L.L.C. Ab Cellera Biologics Inc. Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.29 - $5.97 $133,517 - $185,804	31,123 New	31,123 $140,000
Q2 2023 Aug 11, 2023	BUY	$5.66 - $7.59 $227,939 - $305,664	40,272 New	40,272 $260,000
Q2 2022 Aug 12, 2022	SELL	$5.72 - $10.65 $139,373 - $259,497	-24,366 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$7.46 - $14.14 $181,770 - $344,535	24,366 New	24,366 $238,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.